Very recently and in agreement with our datas, Yu et al, [45], reported that SAA was overexpressed in IMQ treated skin mice, and they further showed that neutralizing anti-SAA antibodies attenuated skin hyperplasia and inflammation this model, demonstrating that SAA contribute to the physiopathology of this psoriasiform-induced dermatitis. The gene discussed is SAA2; the disease is dermatitis.